VRDN Latest Headlines

Viridian Therapeutics Raises $350 Million Through Upsized Convertible Notes and Equity Offerings—Strategic Moves Fuel Robust Pipeline Expansion

Market Chameleon (Thu, 7-May 8:17 AM)

Viridian’s Launch-Ready Pipeline: Veligrotug PDUFA Date Nears and Elegrobart Emerges as First Potential At-Home TED Autoinjector

Market Chameleon (Tue, 5-May 10:32 AM)

Viridian Therapeutics Prepares for TED Launch with Positive Clinical Data and $762M Cash Reserve

Market Chameleon (Tue, 5-May 8:02 AM)

Viridian’s Elegrobart Achieves Major Milestones with Strong Phase 3 Results in Thyroid Eye Disease

Market Chameleon (Mon, 30-Mar 7:29 AM)